2m 2m 2m 2m 2m 2m 2m
NUWELLIS (NUWE)
NASDAQ
$0.50+$0.02 (+3.81%)
Price as of Jun 03, 2026 7:59 PM EDT- $2.1MMarket Cap
- -98.17%1-Year Change
- Medical DevicesIndustry
NUWELLIS (NUWE)
$0.50+$0.02 (+3.81%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 8.3M -5.38% | 8.7M -1.40% | 8.9M +3.76% | 8.5M +7.85% | |
Cost of Revenue | 3.1M +2.68% | 3.1M -21.05% | 3.9M +2.46% | 3.8M +10.44% | |
Gross Profit | 5.1M -9.73% | 5.7M +13.91% | 5.0M +4.79% | 4.8M +5.88% | |
Sales and Marketing Expense | 13.5M +0.47% | 13.5M -21.73% | 17.2M -2.23% | 17.6M -7.64% | |
Research and Development Expense | -2.7M -15.49% | -3.2M -40.82% | -5.4M +24.87% | -4.3M -12.78% | |
Depreciation and Amortization Expense | 200,000 -35.48% | 310,000 -14.36% | 362,000 -2.69% | 372,000 -23.77% | |
Total Operating Expenses | 16.2M -2.60% | 16.7M -26.31% | 22.6M +3.13% | 21.9M -8.71% | |
Operating Profit | -11.1M +1.07% | -11.0M -37.67% | -17.6M +2.67% | -17.2M -12.06% | |
Interest Income | N/A N/A | N/A N/A | 154,000 N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 0 N/A | 0 -100.00% | 154,000 N/A | 0 N/A | |
Total Nonoperating Income and Expense | 10,000 +112.50% | -80,000 -151.95% | 154,000 +105.33% | 75,000 +274.42% | |
Income before Taxes | -17.5M +56.95% | -11.2M -44.76% | -20.2M +39.16% | -14.5M -25.82% | |
Income Taxes | 5,000 0.00% | 5,000 -37.50% | 8,000 -11.11% | 9,000 0.00% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -17.5M +56.93% | -11.2M -44.75% | -20.2M +39.13% | -14.5M -25.81% | |
Net Income from Continuing Operations Applicable to Common | -17.5M +64.88% | -10.6M -53.05% | -22.6M +55.88% | -14.5M -25.82% | |
Basic EPS and Net Income | -25.39 +201.90% | -8.41 -27.00% | -11.52 -86.21% | -83.55 +2,811.15% | |
Diluted EPS and Net Income | -25.39 +201.90% | -8.41 -27.00% | -11.52 -86.21% | -83.55 +2,811.15% | |
Basic Weighted Average Shares | 690,145 -48.00% | 1.3M -32.43% | 2.0M +1,028.97% | 174,000 -97.46% | |
Diluted Weighted Average Shares | 690,145 -48.00% | 1.3M -32.43% | 2.0M +1,028.97% | 174,000 -97.46% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 1.1M -78.70% | 5.1M +34.08% | 3.8M -78.58% | 17.7M -26.72% | |
Short-Term Investments | N/A N/A | N/A N/A | 0 -100.00% | 569,000 N/A | |
Cash and Cash Equivalents and Short-Term Investments | 1.1M -78.70% | 5.1M +34.08% | 3.8M -79.24% | 18.3M -24.37% | |
Total Current Assets | 5.2M -41.43% | 8.9M +7.87% | 8.2M -63.95% | 22.8M -19.05% | |
Accumulated Depreciation | 4.0M +5.29% | 3.8M +8.50% | 3.5M +9.81% | 3.2M +12.45% | |
Property and Plant and Equipment and Net | 368,000 -23.01% | 478,000 -34.34% | 728,000 -25.71% | 980,000 -17.51% | |
Total Long-Term Assets | 271,000 +1,190.48% | 21,000 -82.50% | 120,000 +471.43% | 21,000 0.00% | |
Total Assets | 6.1M -37.98% | 9.9M +0.96% | 9.8M -60.40% | 24.7M -18.88% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 3.0M +18.48% | 2.6M -19.33% | 3.2M -32.34% | 4.7M +41.76% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 67,000 -78.18% | 307,000 -43.57% | 544,000 N/A | 0 -100.00% | |
Total Liabilities | 3.5M +4.62% | 3.3M -49.17% | 6.6M -46.74% | 12.3M +175.53% | |
Retained Earnings | -316.3M +5.86% | -298.8M +3.88% | -287.6M +7.56% | -267.4M +5.73% | |
Total Stockholders Equity | 2.6M -59.80% | 6.5M +118.33% | 3.0M -75.80% | 12.4M -52.38% | |
Total Shares Outstanding | 1.7M -61.43% | 4.4M -23.03% | 5.7M +959.38% | 536,394 -94.91% | |
Cash Flow | |||||
Cash from Operating Activities | -10.8M +12.71% | -9.6M -46.53% | -17.9M +18.40% | -15.1M -15.27% | |
Capital Expenditures | 90,000 +50.00% | 60,000 -59.73% | 149,000 +22.13% | 122,000 -44.29% | |
Cash from Investing Activities | -90,000 +50.00% | -60,000 -118.18% | 330,000 -97.76% | 14.7M +6,825.11% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 6.9M -36.69% | 11.0M +197.64% | 3.7M -60.91% | 9.4M -66.19% | |
Financials Ratio | |||||
Gross Margin | 61.96% -4.59% | 64.94% +15.52% | 56.22% +1.00% | 55.66% -1.83% | |
Operating Margin | -134.29% +6.82% | -125.72% -36.79% | -198.89% -1.05% | -200.99% -18.46% | |
Return on Assets | -219.26% +92.79% | -113.73% -3.08% | -117.35% +122.54% | -52.73% -32.09% | |
Return on Equity | -382.89% +63.20% | -234.61% -10.92% | -263.36% +247.26% | -75.84% -18.14% | |
Revenue Growth | -5.38% +284.42% | -1.40% -137.23% | 3.76% -52.15% | 7.85% +21.73% | |
Current Ratio | 1.71 -50.57% | 3.46 +33.71% | 2.59 -46.71% | 4.86 -42.89% | |
Cash Ratio | 0.36 -82.03% | 1.99 +66.19% | 1.20 -68.34% | 3.78 -48.31% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow